I started out as a cardiovascular primary care sales rep with Merck in the UK.
Julia Walker
Senior Director, Brand Corporate Affairs, AstraZeneca
I started out as a cardiovascular primary care sales rep with Merck in the UK. During that time, the results of the landmark 4S study [Scandinavian Simvastatin Survival Study] made major news on front pages and broadcast outlets around the world. That was my first real taste for what public relations could do and what it was all about. My agency experience really afforded me the best opportunity to get to know our key stakeholder: the media.
I'm most proud of the work I've done on our cholesterol-lowering, atherosclerosis-slowing statin, Crestor. Specifically, the work done by our brand corporate affairs team was a key reason AstraZeneca was able to shift its communications strategy from one of a defensive posture to a more proactive, results-oriented approach. Ultimately, transparent communication of the scientific data for Crestor helped prove the various allegations being made were indeed misleading and inaccurate. Now, thanks to a well-coordinated awareness and education effort, Crestor is helping millions of patients lower their cardiovascular risk, and is the only branded statin that continues to gain market share.
All leaders, at some point in their professional (and probably personal) lives, have operated under the philosophy of "if you want it done right, do it yourself." I'm certainly no exception to that rule. Avoidance of micromanaging is the hardest part of the transition from being a doer to being a manager. The team I've helped build and the agency partners in which I've put my trust have made it easier for me to let go. Still, that doesn't just happen at the drop of a hat. It takes a great deal of work to nurture and mentor a team to be ready to take on roles and responsibilities that you would otherwise handle yourself.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
To Tackle the Plastic Waste Crisis in Pharma, Here’s Where to Start
October 30th 2024By demonstrating big advancements in recycling, pharma companies will be much more likely to attract shareholders and other investors, giving themselves a leg up in the competition to lead the biopharmaceutical industry well into the future.